1. Home
  2. IPWR vs INTS Comparison

IPWR vs INTS Comparison

Compare IPWR & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

HOLD

Current Price

$4.32

Market Cap

26.3M

Sector

Industrials

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.39

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPWR
INTS
Founded
2007
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
24.0M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
IPWR
INTS
Price
$4.32
$0.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.75
$2.25
AVG Volume (30 Days)
87.0K
1.3M
Earning Date
02-26-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,136.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3,233.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$0.19
52 Week High
$7.31
$2.56

Technical Indicators

Market Signals
Indicator
IPWR
INTS
Relative Strength Index (RSI) 62.15 44.17
Support Level $3.15 $0.37
Resistance Level $4.25 $0.42
Average True Range (ATR) 0.47 0.03
MACD 0.09 -0.00
Stochastic Oscillator 67.58 31.21

Price Performance

Historical Comparison
IPWR
INTS

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: